Operating Partner & Executive |  MedTech, HealthTech & Biotech

We work with investors and venture-backed companies to structure, scale and de-risk businesses operating in complex, regulated environments.

From due diligence to hands-on execution, we step in where senior leadership is needed across product, regulatory, go-to-market and operations.

At Alpamed we operate:

  • as Operating Partner supporting investors on due diligence, deal execution and portfolio management.
  • as Scale-Up Executive working directly within teams to structure operations & accelerate growth.

The focus is simple: enable better decisions and ensure execution continues until real market traction.

Based in Zurich, operating across Europe.

Services

For Startups & Scale-Ups


Product, regulatory and go-to-market structuring

Operations and team build-up

Fundraising readiness



  • Structure early to avoid regulatory and go-to-market dead-ends.


    For Investors (VCs, Family Offices)


    Due diligence (scientific, technical, commercial)

    Deal evaluation and thesis validation

    Portfolio company support 



    Challenge assumptions and validate execution risk pre-investment.



    Executive Support


    Interim COO / CTO / CCO 

    Driving execution in critical phases

    Bridging gaps before key hires



    Ensure execution when teams are not yet in place.


    About


    Antoine Bourrier, PhD, founder of Alpamed.

    Entrepreneur and operating partner working with investors and companies across biotech, MedTech and HealthTech.

    13 years of experience spanning research in neuroengineering, startup founding and leadership in global consulting for pharma and MedTech as well venture and family office advisory including due diligence and investment support.

    Antoine focus on situations where companies need to structure, scale or execute under constraints, bridging investment decisions with operational delivery.


    Alpamed Network

    Alpamed works with a network of domain experts, operators and investors across Europe. This allows access to complementary expertise when required, as well as direct interaction with venture capital and family offices in the context of due diligence, fundraising and portfolio support.